Navegar por autor "Huidobro Vence, Gerardo"

Mostrando ítems 1-8 de 8

5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer

2011- Villanueva Millán, María Jesús; Grande Ventura, Carlos; Huidobro Vence, Gerardo
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]
Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

2011- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; Senin Estor, Clara; [et al.]
Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors

2015- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Huidobro Vence, Gerardo; Villanueva Silva, María José; Casal Rubio, Joaquín [et al.]
GGCP041/09: A GALICIAN STUDY OF SECOND-LINE ERLOTINIB IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]
GGCP041/09: A Galician study of second-line erlotinib in patients with advanced non-squamous non-small cell lung cancer (nsNSCLC)

2012- Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; [et al.]
Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

2011- Anido Herranz, Urbano; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Calvo Crespo, Patricia; Vázquez Estévez, Sergio; [et al.]